10:59 AM EST - Acerus Pharmaceuticals Corporation : Has entered into an amending agreement with First Generation Capital Inc., a company affiliated with the Chairman of the Board of Directors of Acerus, to increase its secured loan facility from $25 million U.S. to $30.845 million U.S.. This increase was made available to the Company by way of a single advance under a secured grid promissory note with First Generation. Acerus Pharmaceuticals Corporation
shares T.ASP are trading up $0.005 at $0.04.
